Atara Biotherapeutics (ATRA) Price to Earnings (2014 - 2026)
Atara Biotherapeutics' (ATRA) quarterly Price to Earnings came in at 35.7 in Q2 2026, down 190.5% on a YoY basis from 39.45 in Q2 2025, and down 122.18% quarter-over-quarter from 16.07 in Q1 2026.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Price to Earnings (2014 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has reported Price to Earnings for 13 consecutive years, with 35.7 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Price to Earnings fell 190.5% year-over-year to 35.7; the trailing twelve-month figure through Jun 2026 stood at 7.34 (down 145.18% YoY), and the FY2025 full-year result was 8.77, up 851.75% from the prior year.
- Price to Earnings declined to 35.7 in Q2 2026 per ATRA's latest filing, from 16.07 in the prior quarter.
- Across five years, Price to Earnings topped out at 39.8 in Q2 2022 and bottomed at 45.17 in Q3 2025.
- Historically, Price to Earnings has averaged 4.53 across 5 years, with a median of 3.26 in 2023.
- The widest YoY moves for Price to Earnings: up 1539.1% in 2025, down 1530.45% in 2025.
- Over 5 years, Price to Earnings stood at 4.21 in 2022, then jumped by 78.66% to 0.9 in 2023, then sank by 773.13% to 7.85 in 2024, then slumped by 182.56% to 22.19 in 2025, then slumped by 60.92% to 35.7 in 2026.
- According to Business Quant data, Price to Earnings over the past three periods registered 35.7, 16.07, and 22.19 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Atara Biotherapeutics | 148.00 Mn | 131.45 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.70 |
| Mar 31, 2026 | -16.07 |
| Dec 31, 2025 | -22.19 |
| Sep 30, 2025 | -45.17 |
| Jun 30, 2025 | 39.45 |
| Mar 31, 2025 | 1.68 |
| Dec 31, 2024 | -7.85 |
| Sep 30, 2024 | -2.77 |
| Jun 30, 2024 | -2.74 |
| Mar 31, 2024 | -2.63 |
| Dec 31, 2023 | -0.90 |
| Sep 30, 2023 | -2.16 |
| Jun 30, 2023 | -2.29 |
| Mar 31, 2023 | -3.74 |
| Dec 31, 2022 | -4.21 |
| Sep 30, 2022 | -4.26 |
| Jun 30, 2022 | 39.80 |
| Mar 31, 2022 | -9.85 |
| Dec 31, 2021 | -15.44 |
| Sep 30, 2021 | -18.69 |